Share of people with HIV who receive antiretroviral therapy in Niger
Niger: Share of people with HIV who receive antiretroviral therapy was 66.0% in 2024. ◆ Volatile
Share of people with HIV who receive antiretroviral therapy in Niger, 2000–2024
Source: UNAIDS estimates, via World Bank (2026) – processed by Our World in Data. Measured in % of people living with HIV.
Analysis
The most recent figure for share of people with hiv who receive antiretroviral therapy in Niger is 66.0%, measured in 2024.
Compared with earlier readings it is down 4.3% on the previous year and up 100.0% over ten years.
Over the whole period, share of people with hiv who receive antiretroviral therapy in Niger peaked at 69.0% in 2022 and was at its lowest, 0.0%, in 2000.
That places Niger 87th out of 143 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Share of people with HIV who receive antiretroviral therapy in Niger, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 2.0% | — |
| 2006 | 4.0% | +100.0% |
| 2007 | 6.0% | +50.0% |
| 2008 | 7.0% | +16.7% |
| 2009 | 17.0% | +142.9% |
| 2010 | 19.0% | +11.8% |
| 2011 | 26.0% | +36.8% |
| 2012 | 31.0% | +19.2% |
| 2013 | 34.0% | +9.7% |
| 2014 | 33.0% | -2.9% |
| 2015 | 38.0% | +15.2% |
| 2016 | 44.0% | +15.8% |
| 2017 | 53.0% | +20.5% |
| 2018 | 61.0% | +15.1% |
| 2019 | 63.0% | +3.3% |
| 2020 | 66.0% | +4.8% |
| 2021 | 68.0% | +3.0% |
| 2022 | 69.0% | +1.5% |
| 2023 | 69.0% | +0.0% |
| 2024 | 66.0% | -4.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 3.6% | 0.0% | 17.0% | 10 |
| 2010s | 40.2% | 19.0% | 63.0% | 10 |
| 2020s | 67.6% | 66.0% | 69.0% | 5 |
Countries ranked near Niger
More health data for Niger
- Un projection of annual infant deaths, annual growth rate -1.58 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.35 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 887.5 deaths per 1,000 people (2090)
- Number of infants who die before age 1 22,995 deaths (2100)
- Population ages 80 and above, female, per capita 0.0015 units per person (2025)
- Population ages 80 and above, male, annual growth rate 5.86 % change on previous year (2025)
- Population ages 80 and above, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 80 and above, male, per capita 0.001 units per person (2025)
- Pertussis - number of reported cases, gaps filled 0 (2025)
- Pertussis - number of reported cases, per capita 0 units per person (2025)
Frequently asked questions
- What is share of people with hiv who receive antiretroviral therapy in Niger?
- Share of people with hiv who receive antiretroviral therapy in Niger was 66.0% in 2024, according to UNAIDS estimates, via World Bank (2026) – processed by Our World in Data.
- What is the highest share of people with hiv who receive antiretroviral therapy recorded in Niger?
- The highest recorded value was 69.0% in 2022.
- What is the lowest share of people with hiv who receive antiretroviral therapy recorded in Niger?
- The lowest recorded value was 0.0% in 2000.
- How does Niger rank for share of people with hiv who receive antiretroviral therapy?
- Niger ranks 87th out of 143 countries with data for 2024.
- Is share of people with hiv who receive antiretroviral therapy rising or falling in Niger?
- Over the last ten years it is up 100.0%. The long-run trend across the full record is volatile.
- Where does this Niger data come from?
- The figures come from UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as part of Share of people with HIV who receive antiretroviral therapy. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.